Correction: Does the chemotherapy backbone impact on the efficacy of targeted agents in metastatic colorectal cancer? A systematic review and meta-analysis of the literature

David L. Chan, Nick Pavlakis, Jeremy Shapiro, Timothy J. Price, Christos S. Karapetis, Niall C. Tebbutt, Eva Segelov

Research output: Contribution to journalComment/debate

4 Citations (Scopus)

Abstract

(PLoS ONE (2015) 10:8 (e0135599) DOI: 10.1371/journal. pone.0135599)
There is an error in reference 22. The correct reference is: Peeters M, Price TJ, Cervantes A,Sobrero AF, Ducreux M, Hotko Y, et al. Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer. J Clin Oncol. 2010 Nov 1;28(31):4706-13.Fig 5is incorrect. The authors have provided a corrected version here.
Original languageEnglish
Article numbere0138916
Number of pages1
JournalPLoS One
Volume10
Issue number9
DOIs
Publication statusPublished - 25 Sep 2015

Bibliographical note

Copyright:© 2015 Chan et al. This is an openaccess article distributed under the terms of theCreative Commons Attribution License, which permitsunrestricted use, distribution, and reproduction in anymedium, provided the original author and source arecredited

Keywords

  • cancer
  • chemotherapy
  • colorectal cancer

Fingerprint Dive into the research topics of 'Correction: Does the chemotherapy backbone impact on the efficacy of targeted agents in metastatic colorectal cancer? A systematic review and meta-analysis of the literature'. Together they form a unique fingerprint.

  • Cite this